Evidence map›Paper›PMID 24385757›Full record

ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2013

Human Immunodeficiency Virus (HIV)-Negative and Human Herpes Virus-8 (HHV-8)-Positive Primary Effusion Lymphoma: A Case Report and Review of the Literature.

Sonay Güven Karataş, Reyhan Bayrak, Ozlem Sahin Balçık, Kadir Serkan Yalçın, Esra Atıcı, Umit Akyıldız, Ali Koşar

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sonay Güven KarataşTurgut Özal University, School of Medicine, Department of Internal Medicine, Ankara, Turkey.
Reyhan BayrakTurgut Özal University, School of Medicine, Department of Pathology, Ankara, Turkey.
Ozlem Sahin BalçıkTurgut Özal University, School of Medicine, Department of Hematology, Ankara, Turkey.
Kadir Serkan YalçınTurgut Özal University, School of Medicine, Department of Internal Medicine, Ankara, Turkey.
Esra AtıcıTurgut Özal University, School of Medicine, Department of Internal Medicine, Ankara, Turkey.
Umit AkyıldızTurgut Özal University, School of Medicine, Department of Internal Medicine, Ankara, Turkey.
Ali KoşarTurgut Özal University, School of Medicine, Department of Hematology, Ankara, Turkey.
Turgut Özal University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledPrimary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that presents with serosal effusion in body cavities, without obvious tumor masses. Although PEL occurs in immunocompromised patients that are human immunodeficiency virus (HIV) positive, it also occurs in immunocompetent human herpes virus-8 (HHV-8)-positive patients. Herein we present an immunocompetent, HIV-negative, CD-20-negative, HHV-8-positive patient with pleural effusion that was diagnosed as PEL. The CHOP protocol and talc pleurodesis were administered. HHV-8 plays a causative role in PEL and is important for differentiating PEL from other types of lymphoma. As such, in addition to pleurodesis antiviral treatment should be considered for optimal treatment outcome. CONFLICT OF INTEREST: None declared.

Indexed as

Differential diagnosisHuman herpes virus-8Human immunodeficiency virus (HIV)Pleural effusionPrimary effusion lymphoma

Identifiers

PMID24385757
PMCPMC3781663
OpenAlexW2026489435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.